Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Crossref DOI link: https://doi.org/10.1007/s13300-020-00917-8
Published Online: 2020-09-03
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Williams, David M. https://orcid.org/0000-0001-9206-5837
Evans, Marc
Text and Data Mining valid from 2020-09-03
Version of Record valid from 2020-09-03
Article History
Received: 3 August 2020
First Online: 3 September 2020
Change Date: 8 January 2021
Change Type: Correction
Change Details: The original article can be found online.